USE OF HEPARIN-BINDING EPIDERMAL GROWTH FACTOR INHIBITORS OR INHIBITORS OF ITS RECEPTORS FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF MYELOMA

摘要

The present invention relates to the use of at least one inhibitor of heparin-binding (HB) epidermal growth factor (EGF), or at least one inhibitor of HB-EGF receptors, or ErbB receptors, or at least one inhibitor of associated transduction pathways for the preparation of drugs useful for inducing the apoptosis and/or inhibiting the proliferation of IL-6-dependent plasmocytic tumor cells.